Cargando…
The emerging role of somatic tumor sequencing in the treatment of urothelial cancer
The development of rapid genome sequencing has greatly enhanced our understanding of the molecular biology underlying many malignancies. Whole exome sequencing has highlighted the individualistic nature of malignancies on a patient-to-patient basis and begun to revolutionize therapeutic approaches....
Autores principales: | Wen, Lexiaochuan, Britton, Cameron J., Garje, Rohan, Darbro, Benjamin W., Packiam, Vignesh T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566359/ https://www.ncbi.nlm.nih.gov/pubmed/34765446 http://dx.doi.org/10.1016/j.ajur.2021.06.005 |
Ejemplares similares
-
Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
por: An, Josiah, et al.
Publicado: (2022) -
PARP Inhibitors in Prostate and Urothelial Cancers
por: Garje, Rohan, et al.
Publicado: (2020) -
Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
por: Frydenlund, Noah, et al.
Publicado: (2018) -
Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
por: Garje, Rohan, et al.
Publicado: (2020) -
Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival?
por: Packiam, Vignesh T.
Publicado: (2020)